P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

January 2012

Features

Pharmacotherapy for Post-traumatic Stress Disorder in Combat Veterans

Focus on Antidepressants and Atypical Antipsychotic Agents

Military clinical practice guidelines formerly recommended off-label atypical antipsychotic agents for treating traumatized war veterans. Although the guidelines have been revised, it may be too early to exclude these drugs in all cases.
Walter Alexander

News & Analysis

Pharmacy Groups Want to Change the FDA’s REMS Authority

Battles Loom as Congress Aims to Pass a Major Bill by September 2012

The REMS programs produced by drug companies vary greatly, often making life ­difficult for pharmacists, mainly because so far, the FDA has not established a standard format. The companies also haven’t been too happy with the FDA’s unfocused administration of its REMS authority, which the agency admits needs to be clarified.
Stephen Barlas

How Patient Cost-Sharing Trends Affect Adherence and Outcomes

A Literature Review

Reviewing articles and abstracts published from January 1974 to May 2008, the authors found that increasing patient cost sharing was associated with declines in medication adherence, which in turn were related to poorer health outcomes.
Michael T. Eaddy, PharmD, PhD; Christopher L. Cook, PharmD, PhD; Ken O’Day, PhD, MPA; Steven P. Burch, PhD, RPh; and C. Ron Cantrell, PhD

Meeting Highlights

American Heart Association Scientific Sessions 2011

Topics include extended-release niacin for lowering low-density lipoprotein- cholesterol; vorapaxar for reducing acute coronary syndromes; the use of drug-eluting stents instead of balloon-eluting stents in patients at risk for bleeding; and the impact of free drugs versus copays on adherence to medications.
Walter Alexander

Departments

Medication Errors

Some Red Rules Shouldn't Rule in Hospitals

Matthew Grissinger, RPh, FASCP

Prescription: Washington

Medicare Wants Only ‘Independent’ Consultant Pharmacists in Nursing Homes

Medicare wants to make sure that consultant pharmacists who work in long-term-care facilities have no conflicts of interest.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

FDA approvals, drug indications, and updates

Pharmaceutical Approval Update

Ruxolitinib (Jakafi) for the treatment of myelofibrosis, aflibercept (Eylea) for patients with neovascular (wet) age-related macular degeneration; and cord blood (Hemacord) for stem-cell transplantation
Marvin M. Goldenberg, PhD, RPh, MS

Drug Forecast

Vilazodone HCl (Viibryd)

A Serotonin Partial Agonist and Reuptake Inhibitor for the Treatment of Major Depressive Disorder

Vilazodone (Viibryd) for major depressive disorder
Martin Paspe Cruz, PharmD, CGP, BCPP